Facility 1

Sacramento, California 95821

0 studies enrolling now · 3 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Insomnia Disorder, Thyroid Cancer

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) — Completed
• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma — Completed
• Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) — Completed